Micellae is pleased to announce the appointment of Dr. Andrew Kerklaan as the Company’s new Chief Executive Officer. 

TORONTO, Aug 4, 2021— Micellae Delivery Systems Inc. (“Micellae”) today announced the launch of its breakthrough drug delivery technology, O2W, the fastest oral bioavailability-enhancing formulation.